Abdominal Stent Graft System Market to be Driven by Increase in The Number of Endoscopic Repair Surgeries Performed: Facts & Factors

The Global Abdominal Stent Graft System Market Is Driven by Growing Prevalence of Abdominal Aortic Aneurysm (AAA) and Increase in the Number of Endoscopic Repair Surgeries Performed Globally

The abdominal stent graft is a type of fabric tube that is placed in the aorta and is supported by a metal framework. Abdominal stent graft is placed in the aorta, the main artery that carries blood from the heart to various organs in the body, using a catheter. Abdominal stent graft is mainly used for reducing pressure on the aneurysm and providing a new path for blood flow. The enlargement of an artery, which may be caused due to weakness of the arterial wall, is known as aneurysm. One of the main causes of aneurysm is high blood pressure and atherosclerosis. Wound infections may also cause aneurysm. Stent grafts are primarily used in procedures like an endovascular aortic repair for sealing aortic aneurysms.

Request Market Overview and Sample Report HERE

The abdominal stent graft system market is segmented based on type, application, and region. On the basis of types, the market is classified into catheters, stent graft, syringe needles, and others. In terms of end users, the market is bifurcated into hospitals, ambulatory surgical centers, cardiac specialty centers, and others.

The abdominal stent graft system market research report delivers an acute valuation and taxonomy of the abdominal stent graft system industry by practically splitting the market on the basis of different type, applications, industry vertical, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Request a full TOC of this report Here

Top Market Players

Some of the essential players operating in the abdominal stent graft system market, but not restricted to include MicroPort Scientific Corporation, Medtronic, Endologix, Inc., JOTEC GmbH, Cardinal Health, Inc., Lombard Medical Limited, MAQUET Holding B.V. & Co. KG, Terumo Medical Corporation, among others.